Contraceptive vaccine hCG - Aphton
Alternative Names: Anti-hCG immunocontraceptive - Aphton; Anti-hCG vaccine - Aphton; hCG vaccine - AphtonLatest Information Update: 22 Mar 2007
At a glance
- Originator Aphton Corporation
- Developer Aphton Corporation; World Health Organization
- Class Contraceptives; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pregnancy
Most Recent Events
- 01 Sep 2006 Discontinued - Phase-II for Contraception/Pregnancy (Prevention) in Europe (Parenteral)
- 08 Oct 2003 The phase II trial of the contraceptive vaccine is on hold pending further funding from the WHO